乳腺癌和抑郁症:对印度文学进行全面审查
1Department of Psychiatry, Iqraa International Hospital and Research Centre, Calicut, India.
The primary care companion for CNS disorders
|September 27, 2024
概括
抑郁症影响21.5-83.5%的印度乳腺癌患者,受治疗,耻辱和社会经济因素的影响. 和心理治疗是改善这些患者心理健康的有效干预措施.
科学领域:
- 在瘤学瘤学.
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 乳腺癌在印度是一个重大的健康问题,经常伴随着心理痛苦.
- 抑郁症是乳腺癌患者常见的并发症,影响治疗坚持和生活质量.
研究的目的:
- 在印度背景下,系统地审查乳腺癌患者抑郁症的患病率,相关因素和有效干预措施.
- 突出在癌症护理中需要综合心理健康服务的需要.
主要方法:
- 在PubMed上进行了一项文献搜索,使用关键词"乳腺癌"",抑郁症"和"印度".
- 选择和审查了12项研究,包括原始研究和案例研究.
- 数据提取的重点是患病率,相关性和干预疗效,由两名研究人员进行独立审查.
主要成果:
- 抑郁症的患病率差异很大,在乳腺癌患者中从21.5%到83.5%不等.
- 导致抑郁症的因素包括治疗类型,手术后的身体形象问题,耻辱感,低收入,教育和农村居住.
- 诸如和支持性心理治疗等非药物干预措施在减少抑郁症状方面表现出显著的有效性.
结论:
- 印度乳腺癌患者的抑郁症是一个复杂的问题,受到多种因素的影响.
- 量身定制的干预措施,特别是非药物治疗方法,对于管理抑郁症至关重要.
- 将心理健康服务纳入癌症护理框架对于整体的患者支持和改善心理社会福祉至关重要.
相关概念视频
Depression: Overview
224
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
224
Depressive Disorders: Etiology
55
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
55
Depressive Disorders: MDD and Dysthymia
65
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
65
Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Disorders of the Female Reproductive System
333
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
333


